The video showcases the dedicated team of attorneys at Fulmer Sill as they engage with clients and collaborate in their Oklahoma City office. Scenes highlight their commitment to providing top-notch legal services in their local community.
Advances in modern medicine have led to the development of numerous beneficial and even life-saving drugs. While the majority of these drugs serve to improve the lives, health, and safety of millions of Americans, some pose an unreasonable risk of injury, bodily harm, and death.
With decades of combined legal experience, our Oklahoma City dangerous drug attorneys are prepared to hold the pharmaceutical company accountable for the immense pain and suffering you have experienced. Our firm has earned a reputation for aggressive litigation tactics and a collaborative approach to resolving even the toughest of cases. We offer a high-end, client-focused experience based on our core values of service, communication, integrity, and respect. Our attorneys are ready to represent you and your rights, fighting for the full and fair compensation you are owed.
Schedule a complimentary consultation with one of our defective drug lawyers today; call (405) 510-0077 or contact us online to get started.
Like other consumer goods and products, pharmaceutical drugs and over-the-counter medications may contain a wide variety of defects. Essentially, if a drug has some flaw, or if it poses an unreasonable risk of bodily injury or harm to the consumer, it is considered “defective.”
Some examples of common pharmaceutical drug defects include:
While the Food and Drug Administration (FDA) is responsible for reviewing the safety of new and existing drugs, pharmaceutical companies and manufacturers are the ones who actually conduct drug testing. In most cases, they are also the ones to issue voluntary recalls, though the FDA may issue mandatory recalls on drugs whose risks far outweigh the benefits. All too often, pharmaceutical companies disregard the health and wellbeing of their customers and, instead, prioritize profits over public safety. As a result, millions of people are harmed or even killed by defective and dangerous drugs each year.
When a drug is found to be unsafe or defective, but the safety hazard posed by the drug cannot be corrected, the drug will typically be removed from the market. In some cases, the drug may be recalled, meaning all existing units must be returned. However, in other instances, a pharmaceutical company or manufacturer may decide to simply “withdraw” the drug from the market.
When a drug is withdrawn, the pharmaceutical company stops manufacturing and distributing the drug, but there is no requirement to return existing drugs already on the market. This might be done when numerous people are already using and depending on the drug and returning it or discontinuing use would be potentially dangerous. Unfortunately, this also means that those who already have access to the drug could be at risk of the very safety hazard that instigated the product withdrawal.
Another reason products, including pharmaceutical drugs, are removed from the market rather than recalled is to avoid bad publicity. If a drug becomes the subject of product liability litigation or a class action lawsuit, the pharmaceutical company may experience significant damage to its reputation and profitability. To avoid additional bad press, the company may choose to withdraw the drug from the market, rather than issue an actual recall.
Determining liability for a defective drug involves a complex interplay of legal, regulatory, and factual considerations. Multiple parties involved in the drug’s development, manufacture, distribution, and marketing may potentially bear liability, including:
In Oklahoma, a dangerous drug refers to any medication or pharmaceutical product that poses significant health risks or potential harm to consumers when used as intended.
Injuries associated with dangerous drugs can vary widely, including but not limited to organ damage, birth defects, cardiovascular issues, neurological disorders, and even death.
Victims may pursue legal action through dangerous drug injury claims, seeking compensation for medical expenses, lost wages, pain and suffering, and other damages through lawsuits or settlements.
Yes, Oklahoma has a statute of limitations, typically allowing two years from the date of injury discovery to file a dangerous drug injury claim. It’s crucial to consult with an attorney promptly to ensure compliance with legal deadlines.
Evidence such as medical records, expert testimonies, product labeling, and documentation of adverse reactions can help establish the link between the drug and the injury, strengthening the victim’s case.
Class-action lawsuits involving dangerous drugs may exist, allowing multiple individuals with similar claims to consolidate their cases for efficiency. Victims should inquire with legal professionals regarding ongoing class actions.
Yes, in some cases, victims may be awarded punitive damages in addition to compensatory damages, especially if the defendant’s actions were deemed particularly egregious or reckless.
Absolutely. Consulting with an experienced attorney specializing in dangerous drug injury claims in Oklahoma can provide crucial guidance and representation throughout the legal process, maximizing the chances of a favorable outcome.
Victims can research and contact reputable law firms or legal organizations specializing in personal injury and dangerous drug cases. Additionally, seeking referrals from trusted sources or professional associations can help find competent legal representation.
Reach us online or by phone at (405) 510-0077 o to request your complimentary consultation and case review. Hablamos español
Our client was injured in a pedestrian accident when they were struck by a car.
Settlement for injury to school bus passenger injury in collision resulting from defective maintenance of oil field truck.
Wrongful Death settlement in collision caused by 18-wheeler that lost control while operating in icy road conditions on the interstate.
Settlement on behalf of a client involved in a bad faith denial of heart attack insurance policy benefits.
Settlement arising from death of a pedestrian caused by distracted driver of a box truck.
Settlement obtained on behalf of a client who was involved in a bad faith denial of an Uninsured Motorist claim.